BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
1-Year Return
36.47%
This Quarter Return
+9.6%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$961M
AUM Growth
+$50.3M
(+5.5%)
Cap. Flow
+$2.09M
Cap. Flow
% of AUM
0.22%
Top 10 Holdings %
Top 10 Hldgs %
89.37%
Holding
26
New
1
Increased
5
Reduced
1
Closed
2
Top Buys
| 1 |
Cidara Therapeutics
CDTX
|
+$7.56M |
| 2 |
Cabaletta Bio
CABA
|
+$5.24M |
| 3 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$749K |
| 4 |
Xilio Therapeutics
XLO
|
+$615K |
| 5 |
Annexon
ANNX
|
+$3.2K |
Top Sells
| 1 |
Arcutis Biotherapeutics
ARQT
|
+$9.59M |
| 2 |
Tango Therapeutics
TNGX
|
+$1.39M |
| 3 |
Aclaris Therapeutics
ACRS
|
+$1.1M |
Sector Composition
| 1 | Healthcare | 99.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Arcutis Biotherapeutics
ARQT
$2.07B
| – | – |
-1,030,703
| Closed | -$9.59M |
|